US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

3.21

0.0000

Post-market: 3.220.0100+0.31%17:03 EDT

Volume:415.74K

Turnover:1.34M

Market Cap:255.66M

PE:16.88

High:3.28

Open:3.21

Low:3.19

Close:3.21

52wk High:10.52

52wk Low:2.87

Shares:79.64M

Float Shares:55.82M

Volume Ratio:0.76

T/O Rate:0.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1901

EPS(LYR):0.2000

ROE:21.80%

ROA:5.44%

PB:3.10

PE(LYR):16.05

Loading ...

Overview Company News Filings

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs

Benzinga Earnings

BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million

Niagen Bioscience Inc Outlook FY Revenue Growth 10-15%

THOMSON REUTERS

Niagen Bioscience Inc Q1 EPS USD 0.07 VS. Ibes Estimate USD 0.07

THOMSON REUTERS

Press Release: Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Niagen Bioscience Is Maintained at Buy by Canaccord Genuity

Niagen Bioscience Inc expected to post earnings of 8 cents a share - Earnings Preview

BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering

3 Promising Penny Stocks With Market Caps Under $200M

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), AxoGen (AXGN) and Niagen Bioscience (NAGE)

Pioneer Power Solutions And 2 Other Penny Stocks Worth Watching

Simply Wall St.

BRIEF-Niagen Bioscience Adds Olympia Pharmaceuticals To 503B Compounding Partner Network For Niagen Plus™

Niagen Bioscience partners with Olympia Pharmaceuticals for Niagen Plus compounding, distribution

Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™

THOMSON REUTERS

3 Promising Penny Stocks With Market Caps Over $30M

Simply Wall St.

Niagen Bioscience schedules first-quarter earnings conference call

Promising Penny Stocks To Watch In April 2026

Simply Wall St.

April 2026 Penny Stocks To Watch For Potential Growth

Simply Wall St.

Niagen Bioscience says USP publishes monograph for nicotinamide riboside chloride ingredient

Niagen Bioscience Collaborates With Usp to Establish First-Ever Usp Monograph for Nicotinamide Riboside Chloride (Nrcl), the Patented Form in Niagen®

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NAGE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":3.21,"timestamp":1787601600000,"preClose":3.21,"halted":0,"volume":415735,"hourTrading":{"tag":"盘后","latestPrice":3.22,"preClose":3.21,"latestTime":"17:03 EDT","volume":1666,"amount":5347.869995999999,"timestamp":1787605382592,"change":0.01,"changeRate":0.003115,"amplitude":0.003115},"delay":0,"changeRate":0,"floatShares":55819168,"shares":79644327,"eps":0.190148,"marketStatus":"Post-Mkt","change":0,"latestTime":"08-24 17:30:48 EDT","open":3.21,"high":3.28,"low":3.19,"amount":1340885.6024155,"amplitude":0.028037,"askPrice":3.27,"askSize":1000,"bidPrice":2.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.190148,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":3.21,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.21,"latestTime":"09:12 EDT","volume":5796,"amount":18438.6681612,"timestamp":1787577120251,"change":0.02,"changeRate":0.006231,"amplitude":0.149533},"postHourTrading":{"tag":"盘后","latestPrice":3.22,"preClose":3.21,"latestTime":"17:03 EDT","volume":1666,"amount":5347.869995999999,"timestamp":1787605382592,"change":0.01,"changeRate":0.003115,"amplitude":0.003115},"volumeRatio":0.756029,"impliedVol":0.8647,"impliedVolPercentile":0.1912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":55819168,"roa":"5.44%","roe":"21.80%","lyrEps":0.2,"volumeRatio":0.756029,"shares":79644327,"dividePrice":0,"high":3.28,"amplitude":0.028037,"preClose":3.21,"low":3.19,"week52Low":2.87,"pbRate":"3.10","psRate":"1.98","week52High":10.52,"institutionHeld":0,"latestPrice":3.21,"committee":-0.818182,"eps":0.190148,"divideRate":0,"volume":415735,"delay":0,"ttmEps":0.190148,"open":3.21,"prevYearClose":6.36,"prevWeekClose":3.21,"prevMonthClose":3.4,"prevQuarterClose":3.19,"fiveDayClose":3.04,"twentyDayClose":3.23,"sixtyDayClose":3.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"NAGE","fiscalQuarterEnding":"2026/06","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2026-05-06","symbol":"NAGE","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-08-21","current":17.118245,"percent":0.148876,"low":13.660897,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"high":80.643552,"avg":35.623148,"sd":19.714561,"marketCap":249772956},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-27","current":20.636651,"twenty":24.761026,"median":42.599334,"eighty":62.487416,"marketCap":358706271},{"date":"2026-04-02","current":20.867486,"twenty":24.619893,"median":42.419019,"eighty":62.007672,"marketCap":362718645},{"date":"2026-04-10","current":20.682818,"twenty":24.345467,"median":42.035851,"eighty":61.696037,"marketCap":359508746},{"date":"2026-04-17","current":21.836993,"twenty":23.875024,"median":35.567063,"eighty":61.604905,"marketCap":379570618},{"date":"2026-04-24","current":21.836993,"twenty":23.545172,"median":34.102007,"eighty":61.448036,"marketCap":379570618},{"date":"2026-05-01","current":21.836993,"twenty":23.175836,"median":33.854074,"eighty":61.280145,"marketCap":379570618},{"date":"2026-05-08","current":18.041368,"twenty":22.760333,"median":33.696298,"eighty":61.168218,"marketCap":336236974},{"date":"2026-05-15","current":16.273169,"twenty":22.34483,"median":33.493445,"eighty":60.552618,"marketCap":303283042},{"date":"2026-05-22","current":16.230344,"twenty":22.248072,"median":33.448366,"eighty":60.552618,"marketCap":302484929},{"date":"2026-05-29","current":16.444465,"twenty":22.012428,"median":33.155355,"eighty":60.44668,"marketCap":306475495},{"date":"2026-06-05","current":14.988445,"twenty":21.873927,"median":32.772186,"eighty":60.257509,"marketCap":279339644},{"date":"2026-06-12","current":14.688676,"twenty":21.735571,"median":32.546792,"eighty":59.723377,"marketCap":273752851},{"date":"2026-06-18","current":14.431731,"twenty":21.468256,"median":32.208703,"eighty":59.545333,"marketCap":268964171},{"date":"2026-06-26","current":14.174786,"twenty":20.98752,"median":28.148222,"eighty":59.396403,"marketCap":264175492},{"date":"2026-07-02","current":14.260435,"twenty":20.867486,"median":27.834592,"eighty":59.097565,"marketCap":265771718},{"date":"2026-07-10","current":14.945621,"twenty":20.636651,"median":27.324945,"eighty":58.568512,"marketCap":278541531},{"date":"2026-07-17","current":14.560203,"twenty":20.370149,"median":27.050519,"eighty":58.147287,"marketCap":271358511},{"date":"2026-07-24","current":13.660897,"twenty":20.127155,"median":26.95251,"eighty":57.524987,"marketCap":254598133},{"date":"2026-07-31","current":14.21761,"twenty":20.033066,"median":26.893705,"eighty":56.881406,"marketCap":264973605},{"date":"2026-08-07","current":15.07415,"twenty":19.767151,"median":26.540872,"eighty":56.825443,"marketCap":241050726},{"date":"2026-08-14","current":15.123736,"twenty":19.424638,"median":26.403659,"eighty":56.657552,"marketCap":241843656},{"date":"2026-08-21","current":15.619596,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"marketCap":249772956}],"updateTime":1787586724074},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633590461","title":"Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590461","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590461?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:07","pubTimestamp":1778098038,"startTime":"0","endTime":"0","summary":"Niagen Bioscience reaffirms 2026 sales outlook after first-quarter revenue and profit rose alongside investments in injections and skincare.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/biotech/26/05/52342938/niagen-bioscience-keeps-full-year-sales-forecast-intact-as-q1-revenue-profit-climbs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159984","title":"BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159984","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159984?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097765,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million\n\n\nMay 06 (Reuters) - Niagen Bioscience Inc Q1 net income USD 6.318 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633154911","title":"Niagen Bioscience Inc Outlook FY Revenue Growth 10-15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633154911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633154911?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153159","title":"Niagen Bioscience Inc Q1 EPS USD 0.07 VS. Ibes Estimate USD 0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633153159?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097721,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159904","title":"Press Release: Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159904?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097720,"startTime":"0","endTime":"0","summary":"Net income of $6.3 million, up $1.3 million from the prior year and adjusted EBITDA of $3.8 million. Niagen Bioscience, Inc.  today announced financial results for the first quarter of 2026.--  Total net sales increased 3% to $31.5 million, including $22.4 million. from Tru Niagen. Excluding the recently sold Analytical Reference. Standards and Services segment from both periods, net sales rose 5% to. --  Gross margin of 63.5%, reflecting continued strength in business mix.divestiture of the Analytical Reference Standards and Services operating. --  Basic and diluted earnings per share were $0.08 and $0.07,--  Working capital increased by $5.4 million quarter-over-quarter.increased inventory levels and timing of receivables, ending with $66.5. to increase; general & administrative expense outlook improved to up. --  In May 2026, the Company launched a clinician-directed telehealth. platform under Niagen Plus, enabling eligible U.S. patients to access. --  In April 2026, the Company ann","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4604","BK4588","BK4099","NAGE","TM","03160","BK4121","BK4183","BK4585","BK4232","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633928746","title":"Niagen Bioscience Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2633928746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633928746?lang=en_us&edition=fundamental","pubTime":"2026-05-06 02:59","pubTimestamp":1778007540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 14:59 ET (18:59 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142964","title":"Niagen Bioscience Inc  expected to post earnings of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142964","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142964?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:03","pubTimestamp":1777932185,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc  expected to post earnings of8cents a share - Earnings Preview Niagen Bioscience Inc NAGE.OQ NAGE.O is expected to  show a rise in quarterly revenue when it reports  results on M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H2KG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632953126","title":"BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632953126","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632953126?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:35","pubTimestamp":1777898129,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit OfferingMay 4 (Reuters) - Niagen Bioscience Inc NAGE.O:NIAGEN BIOSCIENCE LAUNCHES NIAGEN PLUS TELEHEAL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA1F1LR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632265018","title":"3 Promising Penny Stocks With Market Caps Under $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2632265018","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632265018?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:05","pubTimestamp":1777568718,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems, potentially offering both stability and upside in today's market landscape.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","BK4579","III","LX","XTNT","BK4123","BK4191","BK4007","MAPS","LU1046422090.SGD","FINV","BK4183","LU1235295612.USD","BK4166","BK4023","BK4134","BK4198","LU0049112450.USD","NEPH","CRCT","VFF","NAGE","BK4531","BK4161","RGP","BABB","SIGA","BK4209","BK4189","BK4121","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631325636","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), AxoGen (AXGN) and Niagen Bioscience (NAGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2631325636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631325636?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:21","pubTimestamp":1777551678,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), AxoGen (AXGN) and Niagen Bioscience (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-axogen-axgn-and-niagen-bioscience-nage-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-axogen-axgn-and-niagen-bioscience-nage-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550494.USD","LU0057025933.USD","LU0211328371.USD","LU0965509101.SGD","IE0002141913.USD","LU0310800379.SGD","LU0456855351.SGD","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU0128525929.USD","LU1244550577.SGD","LU2468319806.SGD","LU0511384066.AUD","LU0320765646.SGD","LU0689472784.USD","BK4534","LU0868494708.USD","LU0472753341.HKD","LU1061106388.HKD","LU0256863902.USD","LU0234570918.USD","LU1291159041.SGD","LU0861579265.USD","LU1496350171.SGD","LU0553294199.USD","LU0098860793.USD","XBI","LU0289739343.SGD","LU1839511570.USD","LU0708994859.HKD","LU2133065610.SGD","NAGE","XLV","LU2089283258.USD","AXGN","HCSG","LABU","LU1551013342.USD","ABBV","LU0795875169.SGD","LU1244550221.USD","LU2089284900.SGD","LU0868494617.USD","BK4139","LU0738911758.USD","LU0795875086.SGD","LU2023251221.USD","LU0211327993.USD","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631858270","title":"Pioneer Power Solutions And 2 Other Penny Stocks Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2631858270","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631858270?lang=en_us&edition=fundamental","pubTime":"2026-04-29 01:05","pubTimestamp":1777395924,"startTime":"0","endTime":"0","summary":"In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9612012-choice2-main-header/1585186803878","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612012-choice2-main-header/1585186803878"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-mrmd/marimed/news/pioneer-power-solutions-and-2-other-penny-stocks-worth-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-mrmd/marimed/news/pioneer-power-solutions-and-2-other-penny-stocks-worth-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4166","BK4007","BK4023","III","BK4583","LU1046422090.SGD","BK4134","VFF","BK4183","PPSI","BK4579","RPID","BK4121","BABB","MRMD","CRCT","LU0049112450.USD","BK4539","SIGA","BK4209","NAGE","BK4182","LX","BK4189","LU1235295612.USD","BK4531","MAPS","BK4191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630071313","title":"BRIEF-Niagen Bioscience Adds Olympia Pharmaceuticals To 503B Compounding Partner Network For Niagen Plus™","url":"https://stock-news.laohu8.com/highlight/detail?id=2630071313","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630071313?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:07","pubTimestamp":1777381657,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Adds Olympia Pharmaceuticals To 503B Compounding Partner Network For Niagen PlusApril 28 (Reuters) - Niagen Bioscience Inc NAGE.O:NIAGEN BIOSCIENCE ADDS OLYMPIA PHARMACEUTICALS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630790304","title":"Niagen Bioscience partners with Olympia Pharmaceuticals for Niagen Plus compounding, distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2630790304","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630790304?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:35","pubTimestamp":1777379749,"startTime":"0","endTime":"0","summary":"Niagen Bioscience entered partnership with Olympia Pharmaceuticals to compound and distribute pharmaceutical-grade Niagen for Niagen Plus intravenous and injectable products.Deal expands Niagen Bioscience 503B outsourcing network alongside Wells Pharma of Houston, diversifying supply chain for clinic demand.Olympia will manufacture liquid compounded vials, widening Niagen Plus product availability across Olympia clinic network.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLYJp4h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304784","title":"Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630304784?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:33","pubTimestamp":1777379598,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630311870","title":"3 Promising Penny Stocks With Market Caps Over $30M","url":"https://stock-news.laohu8.com/highlight/detail?id=2630311870","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630311870?lang=en_us&edition=fundamental","pubTime":"2026-04-28 01:06","pubTimestamp":1777309586,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has remained flat, though it has risen 30% in the past year with earnings forecasted to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential can be particularly rewarding. While the term \"penny stocks\" may seem outdated, it continues to represent smaller or newer companies that offer unique opportunities for investors willing to explore beyond traditional options.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3052000-choice1-main-header/1585187042096","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3052000-choice1-main-header/1585187042096"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-npwr/net-power/news/3-promising-penny-stocks-with-market-caps-over-30m-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-npwr/net-power/news/3-promising-penny-stocks-with-market-caps-over-30m-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4134","BK4183","LU0049112450.USD","LX","BK4583","SIGA","BK4157","NAGE","RAVE","LU1046422090.SGD","FINV","MAPS","INVZ","BK4007","BK4182","BK4121","BK4209","III","BK4531","NPWR","LU1235295612.USD","BABB","BK4023","VFF","BK4166","BK4189","BK4549","BK4579"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629604957","title":"Niagen Bioscience schedules first-quarter earnings conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2629604957","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629604957?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:34","pubTimestamp":1776861280,"startTime":"0","endTime":"0","summary":"Niagen Bioscience schedules first-quarter 2026 earnings release for May 6, 2026, post-market close.Conference call set for May 6, 2026 at 4:30 p.m. ET to discuss results.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLb2C9pn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629778080","title":"Promising Penny Stocks To Watch In April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629778080","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629778080?lang=en_us&edition=fundamental","pubTime":"2026-04-21 01:05","pubTimestamp":1776704752,"startTime":"0","endTime":"0","summary":"The market has climbed 4.0% in the last 7 days and 39% over the past year, with earnings forecast to grow by 16% annually. Though often considered outdated, penny stocks still hold potential when supported by robust financials, offering opportunities that larger firms might overlook. We'll explore several penny stocks that stand out for their financial strength and potential for growth, appealing to investors looking for under-the-radar opportunities.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551735-choice1-main-header/1585186911681","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551735-choice1-main-header/1585186911681"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-aiv/apartment-investment-and-management/news/promising-penny-stocks-to-watch-in-april-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-aiv/apartment-investment-and-management/news/promising-penny-stocks-to-watch-in-april-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LX","MAPS","BK4166","FINV","NAGE","BK4183","BK4539","III","BK4215","AIV.AU","BK4579","BK4007","AIV","BK7509","SMWB","BK4023","BK4531","LFVN","BK4583","LU0049112450.USD","BK7095","BK4121","LU1046422090.SGD","BK4142","TOUR","LU1235295612.USD","SIGA","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628210914","title":"April 2026 Penny Stocks To Watch For Potential Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2628210914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628210914?lang=en_us&edition=fundamental","pubTime":"2026-04-17 01:05","pubTimestamp":1776359119,"startTime":"0","endTime":"0","summary":"The United States market has shown robust performance, rising 3.4% over the last week and 35% over the past year, with earnings projected to grow by 16% annually. In such a thriving market, identifying stocks with strong potential for growth often involves looking beyond well-known names to those that might not be on every investor's radar. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that could offer surprising value and stability...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/april-2026-penny-stocks-to-watch-for-potential-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/april-2026-penny-stocks-to-watch-for-potential-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAPS","BK4142","BK4183","DAVA","LU0084288595.USD","LU1235295612.USD","NAGE","BK4531","BK4007","BK4097","LU0648005311.SGD","BK7511","BK4583","BK7042","BK4023","TOUR","TLS","BK4189","DAVA.AU","III","BK4166","VFF","BK4134","LU0049112450.USD","TLS.AU","BK4139","SIGA","BK4579","BK4121","IFRX","LX","LFVN","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626505182","title":"Niagen Bioscience says USP publishes monograph for nicotinamide riboside chloride ingredient","url":"https://stock-news.laohu8.com/highlight/detail?id=2626505182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626505182?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:34","pubTimestamp":1775738061,"startTime":"0","endTime":"0","summary":"Niagen Bioscience secured publication of United States Pharmacopeia dietary supplement ingredient monograph for nicotinamide riboside chloride, patented form used in Niagen.USP monograph sets pharmacopeial quality benchmark for NRCl, while NMN and NAD+ lack comparable standards.Standard is expected to be codified and enforced in October 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL6DC9dc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182557","title":"Niagen Bioscience Collaborates With Usp to Establish First-Ever Usp Monograph for Nicotinamide Riboside Chloride (Nrcl), the Patented Form in Niagen®","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182557","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182557?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:32","pubTimestamp":1775737920,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA2FC1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}